Injections, Creams, Pellets, Pills, Troches: Which Hormone Delivery Method Is Actually Right for You?

You've finally decided. After months, maybe years, of feeling like a worn-down version of yourself, you're ready to do something about your hormones. And then you start researching, and you hit a wall of options. Injections. Creams. Pellets. Pills. Patches. Troches that dissolve under your tongue. Everyone you talk to has a strong opinion, and somehow every opinion is different.

Here's the part nobody tells you: most of those people aren't wrong. They've just confused what worked for them with what's best for everyone. Those are not the same thing.

The best delivery method isn't a universal answer. It's the one that fits your physiology, your bloodstream, your lifestyle, and your goals.

The delivery method matters more than most people realize, because it determines something the label never quite explains: how the hormone actually behaves once it's in your body. Two people can take the same hormone and have completely different experiences, simply because of how it was delivered. Here's why.

Why Delivery Method Changes Everything

When we talk about hormone delivery, we're really talking about three things. How fast the hormone enters your bloodstream. How steady the level stays. And how predictable that pattern is from person to person.

A hormone that enters quickly and clears quickly produces peaks and valleys. A hormone that enters slowly and steadily produces a flat, stable line. Neither is automatically better. Some people feel their best on a steady line. Others tolerate a gentle rhythm of peaks and troughs just fine, since that's closer to how the body produces hormones on its own.

The trouble starts when a delivery method produces a pattern your body doesn't tolerate well: a peak too high, a trough too low, or a level that swings in a way you feel. That's when people feel off even though they're technically on therapy.

The Three Variables That Actually Matter

Absorption kinetics is how quickly the hormone gets into your system. Half-life is how long it stays before your body clears half of it. Blood-level stability is how flat or how variable the resulting curve is over days or weeks.

Every delivery method is just a different combination of those three variables. Once you understand that, the "which is best" debate mostly dissolves. The better question isn't which method is best. It's which curve fits you.

Testosterone: The Most Debated Delivery Decision

Testosterone has the most delivery options and the loudest opinions, partly because the differences between routes are genuinely large. A comprehensive pharmacokinetic comparison across formulations found that the timing, magnitude, and duration of peak-to-trough testosterone swings vary substantially by route, and that none of the standard formulations actually reproduce the body's natural daily rhythm, where testosterone runs higher in the morning and lower at night.

Intramuscular injections, typically given weekly or every two weeks, create a real peak shortly after the injection and a gradual decline until the next dose. Some people feel great on the peak and flat by the end of the interval. Others feel the swing.

Subcutaneous injections, often given more frequently in smaller doses, tend to produce a gentler, more even curve than intramuscular dosing. A review from the Brigham and Women's men's health research program describes subcutaneous dosing as a safe, practical option with steadier levels between injections than the traditional intramuscular approach, largely because the more frequent, smaller doses smooth out the peak-and-trough pattern.

Topical creams and gels, applied daily, aim for a steadier state but depend heavily on absorption, which varies by skin site. A pharmacokinetic study of testosterone cream applied to scrotal skin found meaningfully faster and higher absorption at that site compared with standard application areas, which is why site matters as much as formulation.

Pellets, inserted under the skin every three to six months, offer real convenience: no daily dosing, no injections to remember. The tradeoff is that once they're in, the dose can't be adjusted. If the level runs too high early on, or too low near the end of the interval, there's no way to correct it until the next insertion.

Troches, which dissolve under the tongue, and nasal gels are less commonly used for testosterone specifically, mainly because absorption through oral mucosa tends to be less consistent from person to person. They're real options some patients specifically ask about, and worth understanding honestly rather than dismissing outright: they can work, but the predictability tends to be lower than injectable or topical routes.

Estradiol and Progesterone: The Same Logic, Different Curves

The delivery conversation isn't unique to testosterone. Estradiol and progesterone follow the same principle: how you take the hormone shapes how it behaves.

Oral estradiol and transdermal estradiol produce strikingly different curves. A pharmacokinetic study comparing a 2 mg oral tablet to a 50 microgram transdermal patch found that oral estradiol spikes to a peak within under an hour and falls off within a few hours, while the patch holds a much steadier, lower level with far less swing. Neither is inherently wrong. Someone who wants convenience and doesn't mind a daily rise and fall may do fine orally. Someone who wants a flatter, more consistent exposure may prefer the patch. Injectable estradiol esters exist as well, following the same peak-then-decline pattern as testosterone injections, just on a different timescale.

Progesterone tells a similar story. Oral micronized progesterone has long been the standard option, and it's well studied precisely because oral progesterone historically had a bioavailability problem: without micronization, very little of it survives the liver's first-pass metabolism intact. Micronization solved enough of that problem to make oral dosing clinically useful, though bioavailability still runs low compared with other routes, which is part of why oral progesterone tends to come with more of the sedating, sleep-related side effect than other forms. Vaginal administration bypasses much of that first-pass effect. A head-to-head pharmacokinetic comparison of two micronized progesterone formulations found that vaginal administration produced meaningfully different absorption and clearance patterns than oral administration of the same drug, underscoring that route, not just dose, drives the outcome. Injectable progesterone exists too, though it's used far less often outside specific clinical contexts, mainly because the other routes usually accomplish the same goal with less discomfort.

What This Looks Like in Practice

A patient in their late forties came in after two years of feeling flat: low energy, a noticeable dip in motivation, and workouts that used to leave them energized now leaving them wiped out for days. An outside provider had started them on a standard weekly intramuscular testosterone injection. The levels on paper looked reasonable, but the patient described feeling great for two or three days after each shot, then increasingly foggy and irritable as the week wore on.

That pattern is not a failure of testosterone therapy. It's a mismatch between the delivery curve and how that particular person's body responds to swings versus steady state. Switching to smaller, more frequent subcutaneous injections smoothed the curve considerably. Within about six weeks, the peak-trough swing the patient had been feeling was largely gone, and the improvement in mood and energy became far more consistent across the week rather than concentrated in the days right after dosing.

Which Route Actually Fits You

There's no universal answer here, and anyone who tells you there is one is selling a preference, not a physiologic fact. A few honest questions help narrow it down. Do you tolerate peaks and troughs well, or do you feel every fluctuation? Do you want the lowest-maintenance option, even if it means less ability to fine-tune once it's started? Are you comfortable with self-injection, or does that rule out an otherwise-reasonable option before you even start?

None of these questions have a wrong answer. They just point toward a different curve.

What to Expect and How Monitoring Works

Whatever route you start with, monitoring is what actually confirms it's working, rather than assuming it is. Initial follow-up labs typically happen around six to eight weeks after starting or changing a protocol, timed to when levels have stabilized for that particular delivery method. After that, monitoring every three to six months is standard once things look settled. This isn't a formality. It's how dose and delivery get fine-tuned to the individual instead of left on a generic starting protocol indefinitely.

Most people notice a shift in energy and mental clarity within four to eight weeks. Changes in body composition and sleep quality tend to take longer, often three to six months, to fully show up. If the first delivery method you try doesn't fit, that's useful information, not a failure. Switching routes is a normal part of finding the right fit, not a sign that hormone therapy itself isn't working for you.

Start with a Conversation

If you're trying to figure out which approach actually fits your body and your life, a free consultation is a reasonable next step. It's a conversation, not a commitment: a chance to ask your questions and understand your options before you decide anything. Because everyone's physiology is genuinely different, that individualized starting point is the whole point. Virtual consultations are available for patients in Texas and Arizona.

This article is for educational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, or recommend any specific therapy, medication, dose, or delivery method. Hormone therapy carries risks and benefits that vary by individual, and some delivery methods or formulations discussed may be used off-label. Always consult a qualified physician before beginning any hormone therapy. Individual results vary.

References

1. Pastuszak AW, Gittelman M, Tursi JP, Jaffe JS, Schofield D, Miner MM. Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age. Andrology. 2022;10(2):209-222. PMID: 34510812

2. Figueiredo MG, Gagliano-Jucá T, Basaria S. Testosterone therapy with subcutaneous injections: a safe, practical, and reasonable option. J Clin Endocrinol Metab. 2022;107(3):614-626. PMID: 34698352

3. Iyer R, Mok SF, Savkovic S, Turner L, Fraser G, Desai R, Jayadev V, Conway AJ, Handelsman DJ. Pharmacokinetics of testosterone cream applied to scrotal skin. Andrology. 2017;5(4):725-731. PMID: 28334510

4. Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol. Arzneimittelforschung. 1996;46(8):766-773. PMID: 9125276

5. Wang H, Liu M, Fu Q, Deng C. Pharmacokinetics of hard micronized progesterone capsules via vaginal or oral route compared with soft micronized capsules in healthy postmenopausal women: a randomized open-label clinical study. Drug Des Devel Ther. 2019;13:2475-2482. PMID: 31440031

6. Sitruk-Ware R, Bricaire C, De Lignières B, Yaneva H, Mauvais-Jarvis P. Oral micronized progesterone: bioavailability, pharmacokinetics, pharmacological and therapeutic implications. A review. Contraception. 1987;36(4):373-402. PMID: 3327648

7. Wallace IR, McKinley MC, Bell PM, Hunter SJ. Sex hormone binding globulin and insulin resistance. Clin Endocrinol (Oxf). 2013;78(3):321-329. PMID: 23121642

8. Laurent MR, Hammond GL, Blokland M, Jardí F, Antonio L, Dubois V, Khalil R, Sterk SS, Gielen E, Decallonne B, Carmeliet G, Kaufman JM, Fiers T, Huhtaniemi IT, Vanderschueren D, Claessens F. Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis. Sci Rep. 2016;6:35539. PMID: 27748448

9. PROMETRIUM (progesterone, USP) Capsules. Prescribing Information. U.S. Food and Drug Administration, Drugs@FDA, Application No. NDA 020843.

You're Not Losing Muscle Because You Got Lazy

You're doing everything right. You still train. You still show up. The weights haven't gotten lighter and your effort hasn't dropped. But somewhere in the last few years, the math stopped working. You put in the same work and get back half the result. Recovery takes longer. The mirror tells a different story than it used to, even though your habits haven't changed.

So you do the thing everyone does. You blame yourself. You decide you've gotten soft, or lazy, or that this is just what getting older feels like. And maybe you went to your doctor, who ran a panel, glanced at it, and told you everything looks normal. You left more confused than when you walked in.

Here's the truth that reframes everything: you're not losing muscle because you got lazy. You're losing it because the signal that builds muscle got quieter, and no amount of effort fully replaces a signal that isn't firing.

What's Actually Happening Inside the Muscle

Muscle isn't built by lifting alone. Lifting creates the demand. What answers that demand is a cascade of biological signals, and testosterone sits near the top of that chain. When testosterone binds to a structure on your muscle cells called the androgen receptor, it switches on a master growth pathway known as mTOR.

Think of mTOR as the muscle's construction foreman. When it's active, it drives protein synthesis, the process that turns the raw material from your diet into new muscle fiber. It also activates satellite cells, the repair crew that rebuilds and reinforces muscle after you train. When the signal is strong, the foreman shows up and the crew gets to work. When the signal weakens, the demand from your training is still there, but fewer workers answer the call.

This is the part conventional advice misses. The research on this is mechanistically clear: testosterone signals through both the androgen receptor and mTOR to produce muscle growth, and when you block either pathway, the growth response falls apart. Effort sets the demand. Hormones determine how much of that demand actually gets met.

The Slow Fade Nobody Warns You About

After about age 35, testosterone in men declines at roughly one to two percent per year. That number sounds small, and at first it is. You don't wake up one morning feeling different. The decline is slow enough that you adapt to it without noticing.

But compound one to two percent over a decade and the gap becomes real. The same workout that built muscle at 35 now barely maintains it at 47. Body composition shifts even when the scale holds steady. Fat creeps in where muscle used to be. And the most frustrating part is that none of this shows up as a dramatic crash. It's a gradual erosion, which is exactly why people blame their own discipline instead of their biology.

The decline is real, measurable, and gradual. That's precisely why it gets mistaken for a personal failing instead of a physiological one.

Why "Normal" Labs Miss the Real Problem

This is where most testosterone testing falls short. When a standard panel checks your testosterone, it usually measures total testosterone, which is everything circulating in your blood. The problem is that most of that testosterone isn't actually available to your muscle cells. It's locked up, bound to a protein called sex hormone-binding globulin, or SHBG.

Only the unbound fraction, called free testosterone, can reach the androgen receptor and switch on the growth signal. And here's the catch that ties the whole story together: SHBG rises as you age. So even if your total testosterone looks respectable on paper, a growing share of it is bound and inactive. The number on your lab report can look fine while the number that actually matters quietly falls.

Two men can walk in with an identical total testosterone of 500. One has low SHBG and plenty of free, available testosterone. The other has high SHBG, and functionally his muscles are working with the testosterone of a man at half that number. Same lab value. Completely different biology. If your panel only measured total testosterone, you'd never know which man you are.

This is the difference between a result that's technically normal and a result that's actually optimal for how you feel and function. The reference range tells you that you fall within the broad population spread. It doesn't tell you whether your biology is doing what you need it to do.

What the Evidence Shows

The relationship between available testosterone and muscle isn't a clinical hunch. In a controlled dose-response trial, researchers gave healthy men carefully graded doses of testosterone and measured the result. Muscle mass and strength increased in direct proportion to the dose. More available testosterone meant more muscle, in a clean, dose-dependent line. This is direct evidence that the amount of testosterone reaching your tissue isn't a minor detail. It's a primary lever on how much muscle you can hold.

Pair that with the mechanistic work showing testosterone driving muscle growth through the androgen receptor and mTOR, and the picture is complete. The signal builds the muscle. The strength of the signal determines the outcome. When the signal fades with age and gets further muted by rising SHBG, the result you see in the mirror is not a character flaw. It's biology following its own rules.

A Patient You Might Recognize

Consider a composite picture drawn from patterns I see often. A patient in their early fifties comes in frustrated. They've trained consistently for years. Over the last two or three years, despite no change in effort, they've watched strength plateau and slowly slip, while a layer of fat settled in that wasn't there before. Their previous doctor ran a testosterone panel, saw a total number inside the reference range, and sent them on their way with a shrug.

When we look closer, the total testosterone is indeed mid-range. But the free testosterone is low, and SHBG is elevated. The available signal is far weaker than the headline number suggested. Nothing about this person's discipline was the problem. The standard panel simply never measured the thing that mattered.

What This Means for You

If you've been blaming yourself for a body that stopped responding, it's worth stepping back and asking whether the real issue was ever effort at all. The honest path forward starts with measuring the right things. That means looking beyond total testosterone to free testosterone, SHBG, and the broader hormonal picture, so you understand what your muscle cells are actually working with.

It's worth being clear-eyed here. Hormone optimization isn't a shortcut, and it isn't for everyone. It requires proper evaluation, ongoing monitoring, and an honest conversation about benefits, individual variability, and what the data does and doesn't support. The point isn't to chase a number. The point is to restore a signal that's been quietly fading, so the work you're already putting in finally produces the result it should.

You were never lazy. The signal got quiet. The work starts with finding out by exactly how much.

Let's Talk

If this sounds like your experience, you don't have to keep guessing. A free consultation is a straightforward conversation about your symptoms, your goals, and whether a deeper look at your hormones makes sense for you. It's bookable virtually, on your schedule. No pressure, no commitment, just a chance to finally get answers that the standard panel never gave you.

This content is for educational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Hormone therapy involves potential risks and benefits that vary by individual and requires evaluation and ongoing monitoring by a qualified physician. Some therapies discussed may involve off-label use. Always consult a licensed healthcare provider before making decisions about your health.

References

1. Basualto-Alarcón C, Jorquera G, Altamirano F, Jaimovich E, Estrada M. Testosterone signals through mTOR and androgen receptor to induce muscle hypertrophy. Med Sci Sports Exerc. 2013;45(9):1712-1720. PMID: 23470307

2. Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001;281(6):E1172-E1181. PMID: 11701431